PDGFRB and ovarian carcinoma: Additionally, mural cell markers [76], such as chondroitin sulfate proteoglycan 4 (Cspg4, also known as NG2), alanyl membrane aminopeptidase (Anpep, also known as CD13), and platelet-derived growth factor receptor beta (Pdgfrb), were upregulated in FOXC2-expressing ovarian cancer cells (Figure 4A).